[1]
Girawan, D. 2026. Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 27, 1 (Apr. 2026), 1–2. DOI:https://doi.org/10.24871/27120261-2.